World ADC 2024
San Deigo San Diego, CA, United StatesJoin Discovery at World ADC, November 4-7 in San Diego. Be sure to stop by Booth 502 and meet with your experts: Emer Clarke, PhD, VP, Cell Biology Christina Moskowitz, […]
Accelerate performance studies for assays subject to IVDR, including early phase clinical trials that test European patient samples.
In clinical trials involving European patients or their samples, adherence to IVDR is mandatory. IVDR necessitates performance studies to provide analytical and clinical evidence, which can lead to increased time and costs in early-phase trials, even when companion diagnostics development is not planned.
Discoveryās Kassel, Germany facility, operating under GCLP/CAP-CLIA standards and aligned with ISO 15189, holds the status of a Health Institution. This unique classification enables our clients to:
Discovery provides complete continuity across our global testing sites by using the same standard operating procedures (SOPs), the same laboratory information management system (LIMS), and one project manager for every global clinical trial.
IVDR Article 5 and Health Institution Status applies for institutions established in the EU only.
Join Discovery at World ADC, November 4-7 in San Diego. Be sure to stop by Booth 502 and meet with your experts: Emer Clarke, PhD, VP, Cell Biology Christina Moskowitz, […]
Join Discovery Life Sciences at ASHG 2024 November 5-9, 2024 | Colorado Convention Center, Denver, Colorado Schedule a Meeting at ASHG ļ»æļ»æļ»æļ»æ
Visit Discovery at Booth #919 during SITC 2024 November 6-10, 2024 | George R. Brown Convention Center, Houston, Texas View Discovery's Poster Presentation at SITC 2024 Presented by Dr. Dirk […]
Copyright Ā© 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing